American Association for Cancer Research
Browse

sorry, we can't preview this file

crc-22-0179-s10.docx (29.42 kB)

Supplementary Table S5 from Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival

Download (29.42 kB)
journal contribution
posted on 2023-04-04, 01:45 authored by Jason Roszik, J. Jack Lee, Yi-Hung Wu, Xi Liu, Masanori Kawakami, Jonathan M. Kurie, Anas Belouali, Simina M. Boca, Samir Gupta, Robert A. Beckman, Subha Madhavan, Ethan Dmitrovsky

Supplementary Table 5: The MD Anderson and Georgetown cohorts 5-year survival rates and differences of 5-year restricted mean survival time in months between NSAID users and non-users for all patients and by stage and histopathology corresponding to Figure 1. The abbreviations are AD (adenocarcinoma) and SCC (squamous cell cancer), respectively.

Funding

HHS | National Institutes of Health (NIH)

Samuel Waxman Cancer Research Foundation (SWCRF)

University of Texas System (UT)

American Cancer Society (ACS)

History

ARTICLE ABSTRACT

NLP and real-world studies conducted in large cohorts explored whether NSAIDs improved survival across NSCLC stages, histopathology, gender, smoking history, or demographic groups. A statistically significant association between NSAID use and NSCLC survival was found. This provides a rationale for future NSAID randomized NSCLC trials.

Usage metrics

    Cancer Research Communications

    Categories

    Keywords

    Cancer PreventionLung CancerBiostatistics

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC